Author details

Full Name

David R Barnidge

Affiliation

ORCID

Career Start Year

1997

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37138663	Analysis of monoclonal immunoglobulins from bone marrow plasma cells using immunopurification and LC-MS.		2023
35344689	Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.	Lancet Haematol	2022
33079696	Development of novel methods for non-canonical myeloma protein analysis with an innovative adaptation of immunofixation electrophoresis, native top-down mass spectrometry, and middle-down <i>de novo</i> sequencing.	Clin Chem Lab Med	2020
30801187	Classification of Plasma Cell Disorders by 21 Tesla Fourier Transform Ion Cyclotron Resonance Top-Down and Middle-Down MS/MS Analysis of Monoclonal Immunoglobulin Light Chains in Human Serum.	Anal Chem	2019
29977017	Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients.	Leukemia	2019
30575105	High sensitivity M-protein detection in a case of light-chain cardiac amyloidosis without evidence of plasma cell dyscrasia.	American Journal of Hematology	2019
30814620	Correction: Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients.	Leukemia	2019
29340623	Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.	Rheumatology (Oxford)	2018
30105838	MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms.	Am J Hematol	2018
28274937	Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical Laboratory.	Clinical and Vaccine Immunology	2017
28337658	Erratum to: Analysis of Monoclonal Antibodies in Human Serum as a Model for Clinical Monoclonal Gammopathy by Use of 21 Tesla FT-ICR Top-Down and Middle-Down MS/MS.	J Am Soc Mass Spectrom	2017
28841203	High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma.	Blood Cancer J	2017
28439985	The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.	Am J Hematol	2017
28004336	Quantification of the IgG2/4 kappa Monoclonal Therapeutic Eculizumab from Serum Using Isotype Specific Affinity Purification and Microflow LC-ESI-Q-TOF Mass Spectrometry.	Journal of the American Society for Mass Spectrometry	2017
28247297	Analysis of Monoclonal Antibodies in Human Serum as a Model for Clinical Monoclonal Gammopathy by Use of 21 Tesla FT-ICR Top-Down and Middle-Down MS/MS.	J Am Soc Mass Spectrom	2017
28295502	Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.	Am J Hematol	2017
27540026	Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.	Clin Chem	2016
26845720	Monitoring free light chains in serum using mass spectrometry.	Clinical Chemistry and Laboratory Medicine	2016
27107835	Laboratory testing in monoclonal gammopathy of renal significance (MGRS).	Clinical Chemistry and Laboratory Medicine	2016
27228216	Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.	Anal Chem	2016
26719571	Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.	Clin Chem	2016
26812875	Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation.	Clinical Chemistry and Laboratory Medicine	2016
26430073	Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration.	Clin Chem	2016
27515443	Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.	Clin Chem	2016
26531705	Monitoring oligoclonal immunoglobulins in cerebral spinal fluid using microLC-ESI-Q-TOF mass spectrometry.	Journal of Neuroimmunology	2015
25916620	Detecting monoclonal immunoglobulins in human serum using mass spectrometry.	Methods	2015
26443406	Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine.	Rapid Commun Mass Spectrom	2015
25999961	Direct evidence of podocyte damage in cardiorenal syndrome type 2: preliminary evidence.	Cardiorenal Med	2015
26598961	Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype.	J Proteome Res	2015
26210595	Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC-MS/MS.	International Immunopharmacology	2015
24552626	Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC-MS/MS.	Journal of Proteome Research	2014
24467232	Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy.	J Proteome Res	2014
25039602	Detecting monoclonal light chains in urine: microLC-ESI-Q-TOF mass spectrometry compared to immunofixation electrophoresis.	British Journal of Haematology	2014
25134970	Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometry.	J Proteome Res	2014
24799527	Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography--tandem mass spectrometry.	Clinical Chemistry	2014
24156651	Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratory.	Critical Reviews in Clinical Laboratory Sciences	2013
22523117	Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia.	Nephrol Dial Transplant	2013
20452587	Washing mineral oil reduces contaminants and embryotoxicity.	Fertility and Sterility	2010
20007860	Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry.	Clinical Chemistry	2010
20022981	Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants.	Clin Chem	2010
19325011	Quantification of urinary albumin by using protein cleavage and LC-MS/MS.	Clin Chem	2009
17317883	LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer.	Clin Chem	2007
15797518	Protein expression profiling of CLL B cells using replicate off-line strong cation exchange chromatography and LC-MS/MS.	Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences	2005
16083281	Quantitative protein expression analysis of CLL B cells from mutated and unmutated IgV(H) subgroups using acid-cleavable isotope-coded affinity tag reagents.	Journal of Proteome Research	2005
15253450	Evaluation of a cleavable stable isotope labeled synthetic peptide for absolute protein quantification using LC-MS/MS.	Journal of Proteome Research	2004
15253448	Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry.	J Proteome Res	2004
12585469	Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards.	Analytical Chemistry	2003
10094768	Extraction method for analysis of detergent-solubilized bacteriorhodopsin and hydrophobic peptides by electrospray ionization mass spectrometry.	Analytical Biochemistry	1999
21662843	A design for low-flow sheathless electrospray emitters.	Analytical Chemistry	1999
9553101	Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry.	Journal of Biological Chemistry	1998